FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3116555797> ?p ?o ?g. }

• W3116555797 endingPage "86" @default.
• W3116555797 startingPage "75" @default.
• W3116555797 abstract "Abstract Background There has been uncertainty about the safety or benefit of angiotensin-converting enzyme (ACE) inhibitors during the COVID-19 pandemic. We used Mendelian randomization using genetic determinants of serum-ACE levels to test whether decreased ACE levels increase susceptibility to SARS-CoV-2 infection or COVID-19 severity, while reducing potential bias from confounding and reverse causation in observational studies. Methods Genetic variants strongly associated with ACE levels, which were nearby the ACE gene, were identified from the ORIGIN trial and a separate genome-wide association study (GWAS) of ACE levels from the AGES cohort. The ORIGIN trial included 4147 individuals of European and Latino ancestries. Sensitivity analyses were performed using a study of 3200 Icelanders. Cohorts from the COVID-19 Host Genetics Initiative GWAS of up to 960 186 individuals of European ancestry were used for COVID-19 susceptibility, hospitalization and severe-disease outcome. Results Genetic variants were identified that explain between 18% and 37% of variance in ACE levels. Using genetic variants from the ORIGIN trial, a standard-deviation decrease in ACE levels was not associated with an increase in COVID-19 susceptibility [odds ratio (OR): 1.02, 95% confidence interval (CI): 0.90, 1.15], hospitalization (OR: 0.86, 95% CI: 0.68, 1.08) or severe disease (OR: 0.74, 95% CI: 0.51, 1.06). Using genetic variants from the AGES cohort, the result was similar for susceptibility (OR: 0.98, 95% CI: 0.89, 1.09), hospitalization (OR: 0.86, 95% CI: 0.66, 1.11) and severity (OR: 0.75, 95% CI: 0.50, 1.14). Multiple-sensitivity analyses led to similar results. Conclusion Genetically decreased serum ACE levels were not associated with susceptibility to, or severity of, COVID-19 disease. These data suggest that individuals taking ACE inhibitors should not discontinue therapy during the COVID-19 pandemic." @default.
• W3116555797 created "2021-01-05" @default.
• W3116555797 creator A5022374956 @default.
• W3116555797 creator A5035461704 @default.
• W3116555797 creator A5035707361 @default.
• W3116555797 creator A5044478333 @default.
• W3116555797 creator A5045827547 @default.
• W3116555797 creator A5048891278 @default.
• W3116555797 creator A5058556843 @default.
• W3116555797 creator A5064306128 @default.
• W3116555797 creator A5088367550 @default.
• W3116555797 date "2020-12-08" @default.
• W3116555797 modified "2023-09-28" @default.
• W3116555797 title "The effect of angiotensin-converting enzyme levels on COVID-19 susceptibility and severity: a Mendelian randomization study" @default.
• W3116555797 cites W1972696558 @default.
• W3116555797 cites W1975663485 @default.
• W3116555797 cites W2005445895 @default.
• W3116555797 cites W2022028563 @default.
• W3116555797 cites W2043600435 @default.
• W3116555797 cites W2103783427 @default.
• W3116555797 cites W2104549677 @default.
• W3116555797 cites W2106036991 @default.
• W3116555797 cites W2119569276 @default.
• W3116555797 cites W2133520037 @default.
• W3116555797 cites W2166320441 @default.
• W3116555797 cites W2398690791 @default.
• W3116555797 cites W2503224871 @default.
• W3116555797 cites W2581452190 @default.
• W3116555797 cites W2805983714 @default.
• W3116555797 cites W2810852503 @default.
• W3116555797 cites W2885870007 @default.
• W3116555797 cites W2942053120 @default.
• W3116555797 cites W2947278243 @default.
• W3116555797 cites W2955177623 @default.
• W3116555797 cites W2999230481 @default.
• W3116555797 cites W3004683659 @default.
• W3116555797 cites W3009912996 @default.
• W3116555797 cites W3009976289 @default.
• W3116555797 cites W3013529907 @default.
• W3116555797 cites W3016572296 @default.
• W3116555797 cites W3017094129 @default.
• W3116555797 cites W3017545174 @default.
• W3116555797 cites W3023640683 @default.
• W3116555797 cites W3023751598 @default.
• W3116555797 cites W3028410545 @default.
• W3116555797 cites W3035819488 @default.
• W3116555797 cites W3036779511 @default.
• W3116555797 cites W3037201712 @default.
• W3116555797 cites W3041475757 @default.
• W3116555797 cites W4252771015 @default.
• W3116555797 doi "https://doi.org/10.1093/ije/dyaa229" @default.
• W3116555797 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7799043" @default.
• W3116555797 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33349849" @default.
• W3116555797 hasPublicationYear "2020" @default.
• W3116555797 type Work @default.
• W3116555797 sameAs 3116555797 @default.
• W3116555797 citedByCount "10" @default.
• W3116555797 countsByYear W31165557972021 @default.
• W3116555797 countsByYear W31165557972022 @default.
• W3116555797 countsByYear W31165557972023 @default.
• W3116555797 crossrefType "journal-article" @default.
• W3116555797 hasAuthorship W3116555797A5022374956 @default.
• W3116555797 hasAuthorship W3116555797A5035461704 @default.
• W3116555797 hasAuthorship W3116555797A5035707361 @default.
• W3116555797 hasAuthorship W3116555797A5044478333 @default.
• W3116555797 hasAuthorship W3116555797A5045827547 @default.
• W3116555797 hasAuthorship W3116555797A5048891278 @default.
• W3116555797 hasAuthorship W3116555797A5058556843 @default.
• W3116555797 hasAuthorship W3116555797A5064306128 @default.
• W3116555797 hasAuthorship W3116555797A5088367550 @default.
• W3116555797 hasBestOaLocation W31165557971 @default.
• W3116555797 hasConcept C104317684 @default.
• W3116555797 hasConcept C106208931 @default.
• W3116555797 hasConcept C126322002 @default.
• W3116555797 hasConcept C135763542 @default.
• W3116555797 hasConcept C153209595 @default.
• W3116555797 hasConcept C156957248 @default.
• W3116555797 hasConcept C27016395 @default.
• W3116555797 hasConcept C2779901538 @default.
• W3116555797 hasConcept C2993967602 @default.
• W3116555797 hasConcept C44249647 @default.
• W3116555797 hasConcept C54355233 @default.
• W3116555797 hasConcept C71924100 @default.
• W3116555797 hasConcept C77350462 @default.
• W3116555797 hasConcept C84393581 @default.
• W3116555797 hasConcept C86803240 @default.
• W3116555797 hasConceptScore W3116555797C104317684 @default.
• W3116555797 hasConceptScore W3116555797C106208931 @default.
• W3116555797 hasConceptScore W3116555797C126322002 @default.
• W3116555797 hasConceptScore W3116555797C135763542 @default.
• W3116555797 hasConceptScore W3116555797C153209595 @default.
• W3116555797 hasConceptScore W3116555797C156957248 @default.
• W3116555797 hasConceptScore W3116555797C27016395 @default.
• W3116555797 hasConceptScore W3116555797C2779901538 @default.
• W3116555797 hasConceptScore W3116555797C2993967602 @default.
• W3116555797 hasConceptScore W3116555797C44249647 @default.
• W3116555797 hasConceptScore W3116555797C54355233 @default.
• W3116555797 hasConceptScore W3116555797C71924100 @default.

• next